Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Thomas Morel

A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.

scientific article published on 31 July 2014

Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group

article

Cost-effectiveness assessment of orphan drugs: a scientific and political conundrum.

scientific article published in February 2013

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort

scientific article published on 09 May 2019

Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™.

scientific article published on 04 July 2016

Market watch: Are orphan drug companies the pick of the pharmaceutical industry?

scientific article published on 01 January 2014

Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures.

scientific article published on 2 November 2017

Publication practices and standards: recommendations from GSK Vaccines' author survey.

scientific article

Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers

scientific article published on 26 May 2016

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

scientific article published on 24 December 2013

Regulatory watch: The orphan drug pipeline in Europe

scientific article

Shining a light in the black box of orphan drug pricing

scientific article